Diabetes News
Stay updated on diabetes with press releases highlighting research, treatments, and innovations in diabetes care. Learn about key developments shaping endocrinology and explore opportunities in diabetes prevention and management.
Feb 11, 2026 at 3:13 PM
Vynleads (OTCQB: VYND) Launches Done With Diabetes™ App, Bringing AI-Powered Daily Lifestyle Support to Blood Sugar and Metabolic Health
ROCK HILL, S.C.--(BUSINESS WIRE)--Vynleads (OTCQB: VYND) Launches AI-Powered Done With Diabetes™ App for Daily Blood Sugar and Metabolic Health Support...
Feb 11, 2026 at 10:23 AM
LifeScan Announces Transformational Partnership with i-SENS to Launch OneTouch® Continuous Glucose Monitoring System
MALVERN, Pa.--(BUSINESS WIRE)--LifeScan (“the “Company”), a world leader in glucose monitoring, today announced a transformational partnership with i-SENS, a global biosensor specialist, to launch a continuous glucose monitoring (“CGM”) system under the OneTouch® Vita brand. The Company and i-SENS expect to launch the CGM products in Germany, Ireland, Portugal, and Belgium by early 2027, with plans to expand into additional markets over time. This announcement reflects LifeScan’s long-term comm...
Feb 11, 2026 at 9:00 AM
National Health Organizations Expand Proactive Care for Seniors With Cadence
NEW YORK--(BUSINESS WIRE)--Cadence today announced new partnerships with Corewell Health, Sharp Rees-Stealy Medical Group, Village Medical, and Yale New Haven Health – a diverse group of academic medical centers, integrated delivery networks, and physician-led organizations taking a more proactive approach to senior care to improve outcomes, ease clinician burden, and help patients stay healthier at home. For seniors in these programs, care continues beyond the doctor’s office. A dedicated Cade...
Feb 10, 2026 at 6:00 PM
Eccogene Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China
SHANGHAI & BOSTON--(BUSINESS WIRE)--Eccogene Announces Positive Topline Results from Phase 1b Trial in China of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist...
Feb 10, 2026 at 9:00 AM
Vida Health Expands Cardiometabolic Care to Include MASH, Addressing a Fast-Growing Obesity-Related Cost Driver
SAN FRANCISCO--(BUSINESS WIRE)--Vida Health today announced the expansion of its clinical portfolio to include support for patients living with MASH....
Feb 10, 2026 at 7:00 AM
CCS and SweetSpot Announce Strategic Partnership to Expand Access to Data-Driven Remote Care for People with Diabetes
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--As diabetes continues to impact more than 40 million Americans, two leading healthcare companies are teaming up to bring care beyond the clinic. CCS, a leading provider of clinical solutions and home-delivered medical supplies for chronic conditions, and SweetSpot, an innovative remote diabetes management company, today announced a strategic partnership to address this gap. Together, CCS and SweetSpot are launching a new pilot program across select U.S. ma...
Feb 6, 2026 at 1:00 PM
Trividia Health, Inc. Initiates Labeling Correction for all TRUE METRIX® Blood Glucose Monitoring Systems
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monitoring Systems (collectively, the “Products”) distributed in the United States, United Kingdom, Mexico, Australia, and the Caribbean. Trividia is updating the E-5 Error Code in the “Messages” section of...
Feb 5, 2026 at 4:05 PM
Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 first quarter ended December 31, 2025. The Company is hosting a conference call today, February 5, 2026, at 4:30 p.m. ET to discuss the results. “We had another quarter of strong execution across all areas of our business and we think Arrowhead is extremely well positioned to build on this progress throughout 2026 and beyond,” said Christopher Anzalone, Ph.D.,...
Feb 5, 2026 at 7:00 AM
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
ACTON, Mass.--(BUSINESS WIRE)--Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care...
Feb 4, 2026 at 8:30 AM
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take steps in achieving their long-term health goals. The newest features will launch nationwide in the coming weeks. Last year, Dexcom introduced AI-driven Smart Food Logging in Stelo, the first over-the-counter glucose biosensor cleared1 by the FDA in the United...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.